Cargando…
A New Method to Model and Predict Progression Free Survival Based on Tumor Growth Dynamics
Progression‐free survival (PFS) has been increasingly used as a primary endpoint for early clinical development. The aim of the present work was to develop a model where target lesion dynamics and risk for nontarget progression are jointly modeled for predicting PFS. The model was developed based on...
Autores principales: | Yu, Jiajie, Wang, Nina, Kågedal, Matts |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080535/ https://www.ncbi.nlm.nih.gov/pubmed/32036626 http://dx.doi.org/10.1002/psp4.12499 |
Ejemplares similares
-
Analysis of Longitudinal‐Ordered Categorical Data for Muscle Spasm Adverse Event of Vismodegib: Comparison Between Different Pharmacometric Models
por: Lu, Tong, et al.
Publicado: (2020) -
A disease model predicting placebo response and remission status of patients with ulcerative colitis using modified Mayo score
por: Moein, Anita, et al.
Publicado: (2023) -
A longitudinal model for the Mayo Clinical Score and its sub-components in patients with ulcerative colitis
por: Kawakatsu, Sonoko, et al.
Publicado: (2021) -
Model‐based prediction of progression‐free survival for combination therapies in oncology
por: Baaz, Marcus, et al.
Publicado: (2023) -
Model‐Informed Therapeutic Dose Optimization Strategies for Antibody–Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration–Approved Antibody–Drug Conjugates?
por: Liao, Michael Z., et al.
Publicado: (2021)